Berger C L, Friedman-Kien A E, DiFranco M, Rehle T, Ostreicher R, Knobler R, Donofrio S, Laubenstein L J, Edelson R L
J Invest Dermatol. 1986 Aug;87(2):280-3. doi: 10.1111/1523-1747.ep12696687.
Monoclonal antibody BE2 recognizes an antigen found on malignant T4+ lymphocytes from cutaneous T-cell lymphoma patients (CTCL). Normal peripheral blood lymphocytes do not express detectable levels of BE2 antigen. Forty-eight percent of patients with the acquired immunodeficiency syndrome (AIDS) had lymphocyte populations that were reactive with monoclonal antibody BE2. Peripheral blood lymphocytes from healthy homosexuals, patients with classical Kaposi's sarcoma or viral syndromes, and healthy normal controls were BE2-. Double-labeling studies demonstrated that BE2+ cells were T lymphocytes. This observation demonstrates that some AIDS patients as well as CTCL patients have circulating cells that express a common lymphocyte abnormality.
单克隆抗体BE2可识别皮肤T细胞淋巴瘤(CTCL)患者恶性T4 +淋巴细胞上发现的一种抗原。正常外周血淋巴细胞不表达可检测水平的BE2抗原。48%的获得性免疫缺陷综合征(AIDS)患者的淋巴细胞群体与单克隆抗体BE2发生反应。来自健康同性恋者、经典卡波西肉瘤或病毒综合征患者以及健康正常对照的外周血淋巴细胞BE2呈阴性。双标记研究表明,BE2 +细胞是T淋巴细胞。这一观察结果表明,一些艾滋病患者以及CTCL患者有表达共同淋巴细胞异常的循环细胞。